Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis
延长利妥昔单抗/奥瑞珠单抗给药间隔与多发性硬化症中IgG水平下降减少相关
期刊:Neurotherapeutics
影响因子:6.9
doi:10.1016/j.neurot.2025.e00554
Rigollet, Camille; Freeman, Sean A; Perriguey, Marine; Stellmann, Jan-Patrick; Graille-Avy, Lisa; Lafontaine, Jean-Christophe; Lemarchant, Bruno; Alberto, Tifanie; Demortière, Sarah; Boutiere, Clémence; Rico, Audrey; Hilézian, Frédéric; Durozard, Pierre; Pelletier, Jean; Maarouf, Adil; Zéphir, Hélène; Audoin, Bertrand